ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,391, issued on Jan. 27, was assigned to Viking Therapeutics Inc. (San Diego).
"Compositions and methods for the treatment of metabolic and liver disorders" was invented by Brian Lian (Rancho Santa Fe, Calif.), Geoffrey E. Barker (Carlsbad, Calif.), Maureen Barnes (San Diego), Kader Yagiz (San Diego) and Erland Stevens (Davidson, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof."
The patent was filed on Aug. 10, 2023, under Application No. 18/447,990.
*For further information, including images, charts and...